TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 2 | 3 | 19 | 5 | -17 | -71 | -10 |
| S | %wins | 0 | 0 | 0 | 0 | 100 | 100 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/3/10 17:42 | 12/1/10 | SOMX | Somaxon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Eagle Michael L | CA | D | S | -67 | 2.68 | 5 | -25 | -40 | 37 | D | 110 | -29 | -50 | -24 | -14 | -12 | 0 | 4 | 2 | 3 | 19 | 5 | -17 | -71 | |
12/24/08 14:44 | 12/23/08 | FVRL | Favrille Inc | DE | Health | BioPrd | Biological Products, (No Diag | Eagle Michael L | CA | D | S | 0 | 0.0250 | 0 | -4 | -14 | 24 | D | |||||||||||||||
12/5/08 19:57 | 12/3/08 | FVRL | Favrille Inc | DE | Health | BioPrd | Biological Products, (No Diag | Eagle Michael L | CA | D | S.a | -1 | 0.0262 | 0 | -25 | -47 | 28 | D | |||||||||||||||
11/25/08 16:32 | 11/24/08 | FVRL | Favrille Inc | DE | Health | BioPrd | Biological Products, (No Diag | Eagle Michael L | CA | D | S | -7 | 0.2900 | 0 | -25 | -47 | 28 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |